Business Trends– category –
-
Atrium Therapeutics Receives FDA IND Clearance for RNA Therapeutic ATR 1072 to Treat PRKAG2 Syndrome, Advancing to Phase 1/2 Corventis Trial
Clival Database USA Overview Atrium Therapeutics announced FDA Investigational New Drug (IND) clearance for ATR 1072, an RNA therapeutic in development for the rare PRKAG2 syndrome. This clearance allows the company to proceed with the P... -
Aurion Biotech Unlocks Keys to Scaling Living Cell Therapies Through Commercialization of Allogeneic Corneal Endothelial Cell Therapy in Japan
Drug Discovery News USA Overview Aurion Biotech CEO Arnaud Lacoste shared critical lessons from the successful commercialization of their allogeneic corneal endothelial cell therapy in Japan, highlighting the need for robust manufacturin... -
Kincell Bio Inaugurates and Expands State-of-the-Art GMP Cell Therapy Manufacturing Facilities in Gainesville and Research Triangle Park
Kincell Bio USA Overview Kincell Bio has opened and expanded GMP cell therapy manufacturing facilities in Gainesville, Florida, and Research Triangle Park, North Carolina, designed to support both autologous and allogeneic cell therapies... -
Umoja Biopharma Secures FDA IND Clearance for UB-VV400, First-in-Industry CD22-Targeted In Vivo CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies
Umoja Biopharma (Press Release) USA Overview Umoja Biopharma has received FDA Investigational New Drug (IND) clearance for UB-VV400, a CD22-targeted in vivo CAR T cell therapy candidate for relapsed/refractory B-cell malignancies. This m... -
Roche Leverages NVIDIA AI Digital Twins for GLP-1 Biomanufacturing Innovation, Targeting 25-40% Capacity Increase and 15-20% Lead Time Reduction
IntuitionLabs Switzerland Overview Roche announced the integration of NVIDIA's AI and digital twin technologies, including BioNeMo, to optimize its biomanufacturing processes for GLP-1 pharmaceuticals. This initiative aims to create virt... -
Kincell Bio Unveils Scalable Allogeneic Cell Therapy Manufacturing Platform for Large-Scale Production with Closed-System Automation
Kincell Bio USA Overview Kincell Bio has launched a scalable allogeneic cell therapy manufacturing platform designed for large-volume production, efficient cell expansion, and closed-system automation. This platform supports diverse cell... -
Italy Commits €6 Billion to Catalyze Renewable Hydrogen Production After EU Endorsement
Hydrogen and Carbon Capture Technology World Expo Italy Overview Italy has officially committed €6 billion, with European Commission approval, to significantly boost its renewable hydrogen production capabilities. This substantial invest... -
Prominence Energy Confirms New Helium and Hydrogen Anomalies at Eyre Project in South Australia via Satellite Spectral Study
Kalkine Australia Overview Prominence Energy has announced new helium and hydrogen anomalies at its Eyre Project in South Australia, confirmed by a satellite spectral study released on June 24, 2026. This latest data reinforces earlier s... -
Dual Hydrogen Milestones: North Sea Offshore Platform Produces Green H2, While Hyundai Unveils Waste-to-Hydrogen Facility in Korea
pv magazine Global Multi-Region Overview The PosHYdon pilot project, the world's first to integrate offshore wind power, natural gas infrastructure, and green hydrogen synthesis, has successfully commenced production on a North Sea platf... -
Pirelli, Pyrum, Synthos, and BASF Partner to Transform End-of-Life Tires into Recycled Materials, Advancing Circular Economy
Tyrepress International Partnership Overview Pirelli, Pyrum, Synthos, and BASF have announced a partnership to transform end-of-life tires into recycled materials for new products. This collaboration aims to achieve product circularity b...
